abstract |
The invention relates to pentafluorosulfanyl-benzoylguanidines of formula (I) and (II) in which R1 and R4 have the meanings which are specified in the requirements. These compounds are suitable as antiarrhythmic drugs with a cardioprotective component for the prophylaxis or treatment of myocardial infarction, as well as for the treatment of angina pectoris. They inhibit preventive and pathophysiological processes in the occurrence of ischemically induced damage, especially in the occurrence of ischemically induced cardiac arrhythmias. |